Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests
- PMID: 33757399
- PMCID: PMC7993379
- DOI: 10.1080/0886022X.2021.1901740
Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests
Abstract
Background: Uremic encephalopathy is defined as cerebral dysfunction due to toxin accumulation in patients with chronic kidney disease (CKD). This condition is characterized by subtle to florid symptoms, and its clinical course is always progressive when untreated but partially reversible with renal replacement therapy. While no test exists to measure subclinical uremic encephalopathy, two tests have been validated to measure minimal hepatic encephalopathy: the critical flicker frequency (CFF) test and the psychometric hepatic encephalopathy score (PHES).
Objective: To use CFF and PHES to measure the prevalence of cerebral dysfunction in individuals with CKD.
Methods: This cross-sectional study included a total of 69 patients with stage-5 CKD. Cutoff points for minimal encephalopathy were established using existing clinical guidelines: ≤39 Hz for CFF and < -4 for PHES. All participants were also screened for cognitive function and depression.
Results: Eighteen cases (26.1%) of cerebral dysfunction linked to uremic encephalopathy were detected with CFF, while twelve (17.4%) were detected by PHES; only six cases (8.7%) were diagnosed by both methods. Half of the cases (50%) had diabetes, and 61% were on hemodialysis. Cognitive function scores did not differ significantly between those receiving dialysis, hemodialysis, or no renal replacement therapy.
Conclusions: It is essential to identify cerebral dysfunction when uremic encephalopathy is in early subclinical stages to reduce preventable events as traffic and work accidents.
Keywords: Critical flicker frequency; cerebral dysfunction; chronic kidney failure; uremia; uremic encephalopathy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.Gastroenterology. 2014 Apr;146(4):961-9. doi: 10.1053/j.gastro.2013.12.026. Epub 2013 Dec 21. Gastroenterology. 2014. PMID: 24365582
-
Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis.Turk J Gastroenterol. 2017 May;28(3):191-196. doi: 10.5152/tjg.2017.16618. Epub 2017 Mar 17. Turk J Gastroenterol. 2017. PMID: 28316320
-
Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.Hepatology. 2007 Apr;45(4):879-85. doi: 10.1002/hep.21586. Hepatology. 2007. PMID: 17393525
-
Review article: the modern management of hepatic encephalopathy.Aliment Pharmacol Ther. 2010 Mar;31(5):537-47. doi: 10.1111/j.1365-2036.2009.04211.x. Epub 2009 Dec 7. Aliment Pharmacol Ther. 2010. PMID: 20002027 Review.
-
Psychometric tests for diagnosing minimal hepatic encephalopathy.Metab Brain Dis. 2013 Jun;28(2):227-9. doi: 10.1007/s11011-012-9336-4. Epub 2012 Sep 21. Metab Brain Dis. 2013. PMID: 22993201 Review.
Cited by
-
Resilience: A Protective Factor from Depression and Anxiety in Mexican Dialysis Patients.Int J Environ Res Public Health. 2021 Nov 14;18(22):11957. doi: 10.3390/ijerph182211957. Int J Environ Res Public Health. 2021. PMID: 34831713 Free PMC article.
-
Morphological brain alterations in dialysis- and non-dialysis-dependent patients with chronic kidney disease.Metab Brain Dis. 2023 Apr;38(4):1311-1321. doi: 10.1007/s11011-022-01150-x. Epub 2023 Jan 16. Metab Brain Dis. 2023. PMID: 36642760
-
Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease.Front Med (Lausanne). 2023 Aug 9;10:1215583. doi: 10.3389/fmed.2023.1215583. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37621458 Free PMC article. Review.
References
-
- Levin A, Tonelli M, Bonventre J, et al. . Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1830–1888. - PubMed
-
- Olano CG, Akram SM, Bhatt H.. Uremic encephalopathy. Treasure Island (FL): StatPearls Publishing; 2021. - PubMed
-
- Vanholder R, De Smet R, Glorieux G, et al. , For the European Uremic Toxin Work Group (EUTox) . Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003;63:1934–1943. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical